Insulin naturally aggregates as dimers and hexamers, whose structures have been extensively analysed by X-ray crystallography. Structural determination of the physiologically relevant insulin monomer, however, is an unusual challenge owing to the dif®culty in ®nding solution conditions in which the concentration of insulin is high enough for crystallization yet the molecule remains monomeric. By utilizing solution conditions known to inhibit insulin assembly, namely 20% acetic acid, crystals of insulin in the monomeric state have been obtained. The crystals are strongly diffracting and a data set extending to 1.6 A Ê has recently been collected. The crystals nominally belong to the space group I422, with unit-cell parameters a = b = 57.80, c = 54.61 A Ê , giving rise to one molecule in the asymmetric unit. Preliminary electron-density maps show that whilst most of the insulin monomer is well ordered and similar in conformation to other insulin structures, parts of the B-chain C-terminus main chain adopt more than one conformation.
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Introduction
Since the isolation of insulin in 1922, this peptide hormone has been the subject of extensive clinical, biochemical and biophysical studies. Human insulin, which consists of an A and a B chain of 21 and 30 amino-acid residues, respectively, interacts with the receptor as a monomer, yet one if its most striking characteristics is its ability to form different association states including dimers, tetramers and hexamers. There appears to be a good physiological explanation for this: hexamer formation helps to ensure complete conversion of proinsulin to insulin, facilitates ef®cient packing of insulin in the pancreatic storage vesicles and may protect the protein from physical and chemical degradation (Dodson & Steiner, 1998; Brange, 1994) .
Structural analyses on insulin show how the monomer is adapted for dimer and hexamer formation (Baker et al., 1988) . The general consistency of the monomer structure in dimers, hexamers and other assemblies seen in the earlier studies gave the misleading impression that the protein conformation observed in these structures largely represents the receptor-binding conformation. It was only when the crystal structure of a completely inactive insulin, made so by introducing a peptide cross-link between the A-chain N-terminus and the B-chain C-terminus, turned out to have exactly the same conformation as that of those obtained in earlier structural studies that it was realised that the B-chain C-terminus undergoes a considerable conformation change on binding to the receptor (Derewenda et al., 1991) . In contrast, it has been demonstrated that the N-terminus of the A chain needs to retain its observed -helical structure for the insulin molecule to remain active (Weiss et al., 2000) .
Insulin dimer formation is driven by the burial of hydrophobic residues on the molecule and by the favourable -strand interactions that are generated between the two B-chain C-termini in the dimer. Consequently, native insulin can only be obtained as a monomer (the state in which the hormone binds to its receptor) at less than micromolar concentrations, which is too low for most biophysical studies. Therefore, to study and crystallize native insulin as a monomer has been very dif®cult. Various tactics have been employed to prevent dimerization. One method, which has proved very successful, is to introduce mutations at the dimer-forming surface which interfere with dimerization without having a detrimental effect on activity. For example, the mutations TyrB163His or ProB283Asp/Lys have produced stable monomeric insulins suitable for solution studies including NMR (Ludvigsen et al., 1994) . In addition, it has been known for some time that insulin dimerization can be totally prevented by dissolving native insulin in 20% acetic acid, even at high concentrations such as 20 mg ml À1 . These conditions have made possible some revealing studies on the insulin monomer in solution which show that the molecule is very mobile, with¯exible surface elements (Weiss et al., 1989) . Since this behaviour generally dis-crystallization papers favours crystal formation, no attempt was made to use the acetic acid conditions for the crystallization of insulin. However, we have recently obtained insulin crystals in the presence of acetic acid, resulting in the ®rst crystal structure of a native (porcine) insulin monomer.
2. Experimental procedure 2.1. Crystallization and data collection Crystals were grown by the hanging-drop vapour-diffusion method. The hanging drops consisted of 2 ml of an insulin solution [20 mg ml À1 in 20%(v/v) acetic acid] mixed with 2 ml of a reservoir solution [20%(v/v) acetic acid and 0.05 M sodium sulfate]. Each drop was suspended over 1 ml of the reservoir solution. Crystals were obtained at 291 K after 2±3 d (Fig. 1) . A single crystal of dimensions 0.2 Â 0.2 Â 0.1 mm was¯ashfrozen at 120 K in a cryoprotectant solution consisting of 60% reservoir and 40% ethylene glycol prior to data collection on station ID14-3 at the ESRF, Grenoble. A 1.6 A Ê data set was collected in a single sweep of 75 , using a 1.0 oscillation angle per image. The data were processed using XDISP, DENZO and SCALEPACK from the HKL package (Otwinowski & Minor, 1997) and SCALE-PACK2MTZ, TRUNCATE and CAD from the CCP4 program suite (Collaborative Computational Project, Number 4, 1994) .
Preliminary structure determination
The monomeric insulin structure was solved by molecular replacement using AMoRe (Navaza, 1994) as implemented in the CCP4 suite (Collaborative Computational Project, Number 4, 1994) . The monomeric subunit of the 2-zinc pig insulin hexamer (Baker et al., 1988) was used as the search model, resulting in a ®nal correlation factor after ®tting of 0.50 and a crystallographic R factor of 0.51. Five cycles of maximum-likelihood re®nement were then carried out using REFMAC (Collaborative Computational Project, Number 4, 1994) , after which the crystallographic R factor had dropped to 0.42 (R free = 0.46). 2F o À F c and F o À F c electron-density maps were then examined using XFIT in QUANTA (Old®eld, 2001) and preliminary rebuilding of the structure was carried out.
Results and discussion
The data were indexed in space group I422, with unit-cell parameters a = b = 57.80, c = 54.61 A Ê . The crystals contain one monomer in the asymmetric unit, corresponding to a solvent content of 37.0%. The data set was 98.7% complete between 20.0 and 1.6 A Ê resolution, with an overall merging R value of 0.03. Other data statistics are shown in Table 1 . The crystal packing interactions of the newly solved structure revealed that the insulin monomer, in the absence of normal dimer formation, was able to form an alternative packing arrangement supported by interactions between the B9±B19 -helices of two adjacent monomers centred around residue HisB10. After some preliminary re®nement, 2F o À F c and F o À F c electron-density maps showed that the A-chain residues and the B-chain residues from AsnB3 to GlyB20 were well de®ned. However, electron density for the B-chain C-terminal residues B25±B30 was essentially absent, indicating that this part of the molecule is highly¯exible when not involved in dimer formation. This observation supports the notion that the B-chain C-terminus undergoes a considerable conformational rearrangement during receptor binding.
The insulin monomers are arranged in the crystal in such a way that the B-chain C-termini are in close proximity around the crystallographic fourfold axis, making well ordered packing of residues B26±B30 sterically impossible. For residues B21±B25 there was fragmented electron density indicative of multiple conformations for this part of the molecule. However, subsequent re®nement of the overall structure did not improve the electron-density maps around residues B20±B25 suf®ciently to allow model building in this region. It was then considered that the close proximity of these residues to the crystallographic fourfold axis might coincide with a breakdown in the I422 symmetry of the molecule in this region and that reassignment of the crystal to a lower symmetry space group might allow individual conformations at B20±B25 to be iden-ti®ed. Therefore, it will be necessary to recollect the data and resolve the structure in a lower symmetry space group. The resulting structure will be described in detail in a future paper.
Figure 1
Crystals of porcine insulin grown in 20% acetic acid and 0.05 M sodium sulfate. 
